SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Feb-24 4:56 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-24 | Sale (Planned) | 1,738 | $418.77 | $727,822.00 | (9%) 20.02K to 18.28K | |
13-Feb-24 4:56 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 1,588 | $422.74 | $671,311.00 | (7%) 21.61K to 20.02K | |
08-Feb-24 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 4,743 | -- | -- | 28% 16.86K to 21.61K | |
08-Feb-24 4:28 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 6,294 | -- | -- | 60% 10.57K to 16.86K | |
03-Oct-23 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Oct-23 | Sale (Planned) | 610 | $346.76 | $211,524.00 | (5%) 11.18K to 10.57K | |
03-Oct-23 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Sep-23 | Payment of Exercise | 408 | $350.72 | $143,094.00 | (4%) 11.59K to 11.18K | |
03-Feb-23 4:39 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 6,293 | -- | -- | 119% 5.29K to 11.59K | |
21-Sep-22 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Sep-22 | Grant | 5,294 | -- | -- | 100% 0 to 5.29K | |
23-Feb-22 4:10 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-22 | Payment of Exercise | 2,688 | $29.08 | $78,167.00 | (10%) 25.64K to 22.95K | |
23-Feb-22 4:10 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 18-Feb-22 | Option Exercise | 8,523 | -- | -- | 50% 17.12K to 25.64K | |
14-Feb-22 4:08 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 10-Feb-22 | Payment of Exercise | 1,349 | $31.42 | $42,392.30 | (7%) 18.47K to 17.12K | |
14-Feb-22 4:08 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 10-Feb-22 | Option Exercise | 3,667 | -- | -- | 25% 14.8K to 18.47K | |
07-Dec-21 4:18 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 03-Dec-21 | Payment of Exercise | 1,823 | $35.88 | $65,405.80 | (11%) 16.62K to 14.8K | |
07-Dec-21 4:18 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 03-Dec-21 | Option Exercise | 5,753 | -- | -- | 53% 10.87K to 16.62K | |
07-Dec-20 6:21 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 03-Dec-20 | Payment of Exercise | 1,707 | $45.87 | $78,300.10 | (15%) 11.75K to 10.04K | 9% |
07-Dec-20 6:21 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 03-Dec-20 | Option Exercise | 5,753 | -- | -- | 96% 5.99K to 11.75K | |
15-Apr-20 4:27 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 14-Apr-20 | Payment of Exercise | 2,529 | $40.64 | $102,779.00 | (30%) 8.52K to 5.99K | (3%) |
15-Apr-20 4:27 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Apr-20 | Option Exercise | 8,523 | -- | -- | 100% 0 to 8.52K | |
22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 20,387 | -- | -- | 285% 7.14K to 27.53K | |
22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 26,652 | -- | -- | (97%) 27.53K to 0.88K | |
22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 878 | -- | -- | (100%) 0.88K to 0 | |
04-Nov-19 4:05 PM View: | Celgene Corporation (CELG) | 31-Oct-19 | Payment of Exercise | 1,044 | $108.03 | $112,783.00 | (13%) 8.19K to 7.14K | |
04-Nov-19 4:05 PM View: | Celgene Corporation (CELG) | 31-Oct-19 | Option Exercise | 3,125 | -- | -- | 62% 5.06K to 8.19K | |
06-May-19 4:05 PM View: | Celgene Corporation (CELG) | 02-May-19 | Payment of Exercise | 490 | $95.21 | $46,652.90 | (9%) 5.55K to 5.06K | |
06-May-19 4:05 PM View: | Celgene Corporation (CELG) | 02-May-19 | Option Exercise | 1,563 | -- | -- | 39% 3.99K to 5.55K | |
18-Dec-18 6:45 PM View: | Celgene Corporation (CELG) | 16-Dec-18 | Payment of Exercise | 935 | $68.20 | $63,767.00 | (20%) 4.73K to 3.79K | (33%) |
18-Dec-18 6:45 PM View: | Celgene Corporation (CELG) | 16-Dec-18 | Option Exercise | 1,900 | -- | -- | 67% 2.83K to 4.73K |